Archives
Chicken GSDME Drives RNA Virus-Induced Pyroptosis
2026-09-21
The reference study identifies chicken GSDME as a major pore-forming effector of RNA virus-induced pyroptosis, addressing a longstanding gap caused by the absence of canonical GSDMD in chickens. Using infection, Poly(I:C) stimulation, pathway analysis, and genetic loss-of-function in DF-1 cells, the authors connect MDA5 signaling with caspase activation, GSDME cleavage, pyroptosis, and viral release.
Cy5-UTP for RNA Probes in Neuronal Trafficking
2026-09-20
Use Cy5-UTP to convert T7 in vitro transcription into a direct, far-red RNA probe workflow for FISH, neuronal compartment mapping, and dual-color expression arrays. Applied alongside protein and transport assays, it helps distinguish RNA localization from TIA1 granule trafficking and aggregation.
Mitochondrial Permeability Transition Pore Assay Kit
2026-09-19
This scenario-based guide explains how Mitochondrial Permeability Transition Pore Assay Kit SKU K2061 supports mitochondrial permeability transition pore detection alongside viability, ROS, and apoptosis workflows. It covers assay principles, protocol parameters, interpretation, controls, and practical vendor-selection criteria for cell death mechanism research.
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-09-18
Turn transient mRNA expression into a sensitive, quantitative readout for delivery studies, gene regulation, viability testing, and imaging. This workflow combines Cap1/poly(A)-optimized reporter RNA with practical formulation controls and recent mRNA-LNP insights.
Cy5 maleimide (non-sulfonated) Protocol
2026-09-18
Cy5 maleimide (non-sulfonated), SKU A8139, is a thiol-reactive reagent for fluorescently labeling cysteine-containing peptides and proteins through stable thioether formation. It is appropriate for site-directed protein tracking and fluorescence imaging when an accessible thiol is available, but its low aqueous solubility makes it unsuitable for direct addition as an unformulated aqueous stock or for non-thiol conjugation workflows.
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-17
Pair direct Cy5 visualization with luciferase output to separate mRNA uptake from productive translation in one experimental design. This dual-reporter workflow supports mRNA delivery optimization, intracellular trafficking studies, and better-informed comparisons of transient versus more durable expression systems.
NDRG1–HIF1α Signaling in Pulmonary Hypertension
2026-09-17
A recent study identifies a feed-forward NDRG1–HIF1α circuit that links hypoxic signaling to metabolic reprogramming and pulmonary vascular remodeling. Its use of complementary cell and mouse models suggests that disrupting this axis, including with Voglibose, may reduce pulmonary hypertension phenotypes, although clinical relevance remains unestablished.
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-09-16
The reference study developed a dendritic-cell carrier for directing fluorescently labeled amikacin into Mycobacterium avium granulomas in infected mice. Its findings support cell-mediated localization as a potential way to increase antibiotic exposure at infected tissue while reducing reliance on high systemic doses, although the study primarily established delivery rather than definitive therapeutic superiority.
Cy7 NHS Ester: Practical Protein Labeling Guide
2026-09-16
Cy7 NHS ester (SKU A8109) provides a water-soluble, sulfonated near-infrared labeling option for proteins and peptides containing accessible amino groups. It is appropriate for controlled biomolecule conjugation and near-infrared imaging workflows, but the reagent should not be stored as a solution long term or treated as a universal label for targets lacking suitable primary amines.
LY-411575: Gamma-Secretase Inhibitor Workflow
2026-09-15
LY-411575 enables controlled inhibition of amyloid beta production while simultaneously exposing Notch pathway effects in cell and translational models. This practical guide connects dose-response design, synaptic-function assays, and troubleshooting for Alzheimer’s disease research and exploratory cancer research.
TCEP hydrochloride for Capture-and-Release LFAs
2026-09-15
TCEP hydrochloride offers a water-soluble, thiol-free route for reducing cleavable disulfide linkers in capture-and-release lateral flow workflows. Used after complex capture and washing, it can help translate high-affinity rebinding concepts into a controlled assay-development strategy while preserving compatibility with protein and analytical workflows.
Metal-Chelating l-Phe Nanostructures Sensitize Tumors
2026-09-14
A Nature Nanotechnology study shows that metal-ion-chelating l-phenylalanine nanostructures can reverse key features of an immunosuppressive tumor microenvironment and improve immune checkpoint blockade responses. Its mechanistic advance is the integration of short-term starvation, ion-channel regulation, dendritic-cell activation, and tumor-specific cytotoxic T-cell responses.
Cytochalasin B: Actin Assay Workflows
2026-09-14
Cytochalasin B (NSC 107658) provides a reversible way to perturb actin-dependent motility, division, uptake, and transport while preserving time-resolved experimental control. This guide turns that mechanism into practical dose-finding, imaging, functional, and cytotoxicity workflows with troubleshooting strategies for cleaner interpretation.
ASB3 Suppresses Antiviral Immunity via MAVS
2026-09-13
The 2024 Cell Death & Differentiation study identifies ASB3 as an inducible E3 ubiquitin ligase that weakens antiviral innate immunity by directing MAVS toward K48-linked ubiquitination and proteasomal degradation. Its cellular and animal experiments connect ASB3 activity with reduced interferon signaling and increased influenza susceptibility, while providing a mechanistic framework for studying regulation of RIG-I-like receptor pathways.
ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors
2026-09-12
The reference study shows that ATRX-deficient high-grade glioma cells are more vulnerable to several multi-targeted receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient cells. Its combination data with temozolomide support ATRX status as a useful biomarker for interpreting RTK-inhibitor responses in glioma research, while also highlighting the need for genotype-stratified validation.
617 records 8/42 page Previous Next First page 上5页 678910 下5页 Last page